Racial/ethnic disparities at the end of an HIV epidemic

Persons who inject drugs in New York City, 2011-2015

Don Des Jarlais, Kamyar Arasteh, Courtney Mcknight, Jonathan Feelemyer, Susan Tross, David Perlman, Samuel Friedman, Aimee Campbell

Research output: Contribution to journalReview article

Abstract

Objectives. To examine whether racial/ethnic disparities persist at the "end of the HIV epidemic" (prevalence of untreated HIV infection < 5%; HIV incidence < 0.5 per 100 person-years) among persons who inject drugs (PWID) in New York City. Methods.We recruited 2404 PWID entering New York City substance use treatment in 2001 to 2005 and 2011 to 2015. We conducted a structured interview, and testing for HIV and herpes simplex virus 2 (HSV-2; a biomarker for high sexual risk). We estimated incidence by using newly diagnosed cases of HIV. Disparity analyses compared HIV, untreated HIV, HIV-HSV-2 coinfection, HIV monoinfection, and estimated HIV incidence among Whites, African Americans, and Latinos. Results. By 2011 to 2015, Whites, African Americans, and Latino/as met both criteria of our operational "end-of-the-epidemic" definition. All comparisons that included HIV-HSV-2-coinfected persons had statistically significant higher rates of HIV among racial/ethnic minorities. No comparisons limited to HIV monoinfected persons were significant. Conclusions. "End-of-the-epidemic" criteria were met among White, African American, and Latino/a PWID in New York City, but elimination of disparities may require a greater focus on PWID with high sexual risk.

Original languageEnglish (US)
Pages (from-to)1157-1163
Number of pages7
JournalAmerican Journal of Public Health
Volume107
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

HIV
Human Herpesvirus 2
Pharmaceutical Preparations
Hispanic Americans
African Americans
HIV-2
Incidence
Coinfection
HIV Infections
Biomarkers
Interviews

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Racial/ethnic disparities at the end of an HIV epidemic : Persons who inject drugs in New York City, 2011-2015. / Des Jarlais, Don; Arasteh, Kamyar; Mcknight, Courtney; Feelemyer, Jonathan; Tross, Susan; Perlman, David; Friedman, Samuel; Campbell, Aimee.

In: American Journal of Public Health, Vol. 107, No. 7, 01.07.2017, p. 1157-1163.

Research output: Contribution to journalReview article

Des Jarlais, Don ; Arasteh, Kamyar ; Mcknight, Courtney ; Feelemyer, Jonathan ; Tross, Susan ; Perlman, David ; Friedman, Samuel ; Campbell, Aimee. / Racial/ethnic disparities at the end of an HIV epidemic : Persons who inject drugs in New York City, 2011-2015. In: American Journal of Public Health. 2017 ; Vol. 107, No. 7. pp. 1157-1163.
@article{3c41e2cf2fbc4d2f8d9fdaec00a495a8,
title = "Racial/ethnic disparities at the end of an HIV epidemic: Persons who inject drugs in New York City, 2011-2015",
abstract = "Objectives. To examine whether racial/ethnic disparities persist at the {"}end of the HIV epidemic{"} (prevalence of untreated HIV infection < 5{\%}; HIV incidence < 0.5 per 100 person-years) among persons who inject drugs (PWID) in New York City. Methods.We recruited 2404 PWID entering New York City substance use treatment in 2001 to 2005 and 2011 to 2015. We conducted a structured interview, and testing for HIV and herpes simplex virus 2 (HSV-2; a biomarker for high sexual risk). We estimated incidence by using newly diagnosed cases of HIV. Disparity analyses compared HIV, untreated HIV, HIV-HSV-2 coinfection, HIV monoinfection, and estimated HIV incidence among Whites, African Americans, and Latinos. Results. By 2011 to 2015, Whites, African Americans, and Latino/as met both criteria of our operational {"}end-of-the-epidemic{"} definition. All comparisons that included HIV-HSV-2-coinfected persons had statistically significant higher rates of HIV among racial/ethnic minorities. No comparisons limited to HIV monoinfected persons were significant. Conclusions. {"}End-of-the-epidemic{"} criteria were met among White, African American, and Latino/a PWID in New York City, but elimination of disparities may require a greater focus on PWID with high sexual risk.",
author = "{Des Jarlais}, Don and Kamyar Arasteh and Courtney Mcknight and Jonathan Feelemyer and Susan Tross and David Perlman and Samuel Friedman and Aimee Campbell",
year = "2017",
month = "7",
day = "1",
doi = "10.2105/AJPH.2017.303787",
language = "English (US)",
volume = "107",
pages = "1157--1163",
journal = "American Journal of Public Health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
number = "7",

}

TY - JOUR

T1 - Racial/ethnic disparities at the end of an HIV epidemic

T2 - Persons who inject drugs in New York City, 2011-2015

AU - Des Jarlais, Don

AU - Arasteh, Kamyar

AU - Mcknight, Courtney

AU - Feelemyer, Jonathan

AU - Tross, Susan

AU - Perlman, David

AU - Friedman, Samuel

AU - Campbell, Aimee

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Objectives. To examine whether racial/ethnic disparities persist at the "end of the HIV epidemic" (prevalence of untreated HIV infection < 5%; HIV incidence < 0.5 per 100 person-years) among persons who inject drugs (PWID) in New York City. Methods.We recruited 2404 PWID entering New York City substance use treatment in 2001 to 2005 and 2011 to 2015. We conducted a structured interview, and testing for HIV and herpes simplex virus 2 (HSV-2; a biomarker for high sexual risk). We estimated incidence by using newly diagnosed cases of HIV. Disparity analyses compared HIV, untreated HIV, HIV-HSV-2 coinfection, HIV monoinfection, and estimated HIV incidence among Whites, African Americans, and Latinos. Results. By 2011 to 2015, Whites, African Americans, and Latino/as met both criteria of our operational "end-of-the-epidemic" definition. All comparisons that included HIV-HSV-2-coinfected persons had statistically significant higher rates of HIV among racial/ethnic minorities. No comparisons limited to HIV monoinfected persons were significant. Conclusions. "End-of-the-epidemic" criteria were met among White, African American, and Latino/a PWID in New York City, but elimination of disparities may require a greater focus on PWID with high sexual risk.

AB - Objectives. To examine whether racial/ethnic disparities persist at the "end of the HIV epidemic" (prevalence of untreated HIV infection < 5%; HIV incidence < 0.5 per 100 person-years) among persons who inject drugs (PWID) in New York City. Methods.We recruited 2404 PWID entering New York City substance use treatment in 2001 to 2005 and 2011 to 2015. We conducted a structured interview, and testing for HIV and herpes simplex virus 2 (HSV-2; a biomarker for high sexual risk). We estimated incidence by using newly diagnosed cases of HIV. Disparity analyses compared HIV, untreated HIV, HIV-HSV-2 coinfection, HIV monoinfection, and estimated HIV incidence among Whites, African Americans, and Latinos. Results. By 2011 to 2015, Whites, African Americans, and Latino/as met both criteria of our operational "end-of-the-epidemic" definition. All comparisons that included HIV-HSV-2-coinfected persons had statistically significant higher rates of HIV among racial/ethnic minorities. No comparisons limited to HIV monoinfected persons were significant. Conclusions. "End-of-the-epidemic" criteria were met among White, African American, and Latino/a PWID in New York City, but elimination of disparities may require a greater focus on PWID with high sexual risk.

UR - http://www.scopus.com/inward/record.url?scp=85020489505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020489505&partnerID=8YFLogxK

U2 - 10.2105/AJPH.2017.303787

DO - 10.2105/AJPH.2017.303787

M3 - Review article

VL - 107

SP - 1157

EP - 1163

JO - American Journal of Public Health

JF - American Journal of Public Health

SN - 0090-0036

IS - 7

ER -